Anti-EphA3 CAR-T cell therapy (Humanigen)

Product Name :
Anti-EphA3 CAR-T cell therapy (Humanigen)

Search keywords :
EPHA3

drugId :
null

Target Vo:
Ephrin type-A receptor 3

Target Vo Short Name :
EphA3

Moa_Name:
Anti-Ephrin type-A receptor 3

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Humanigen Inc

Active Company_Name :
Humanigen Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Proteasome beta 8 Antibody (YA684)
PDCD4 Antibody
Glutathione Peroxidase 4 Antibody: Glutathione Peroxidase 4 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 22 kDa, targeting to Glutathione Peroxidase 4. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts